Morphoceuticals Announces Roger Pomerantz, MD, as Chairman of its Board of Directors
MEDFORD, Mass., July 22, 2025 (GLOBE NEWSWIRE) -- Morphoceuticals Inc., a TechBio company pioneering AI-guided electroceuticals for tissue repair and organ regeneration, today announced the appointment of industry veteran Roger Pomerantz, MD, as Chairman of its Board of Directors. Pomerantz joins as an independent director. The company is advancing a novel technology platform, based on the first ever atlas of the bioelectrome - the electrical networks by which cells communicate throughout the body, powered by the movement of ions creating voltage patterns. These electrical networks enable cells to work together to take shape into tissues and organs and allow for previously unexplored therapeutic strategies based on tissue repair and organ regeneration.
Pomerantz has led the development of 14 large and small molecule therapies, and a breakthrough microbiome therapeutic, that have all won FDA approval. He currently serves on the Boards of Directors for multiple life sciences companies, including Enlivex Therapeutics, Indaptus Therapeutics, 1E Therapeutics and CollPlant. He was the President, CEO and Chairman of Seres Therapeutics, the first publicly traded microbiome therapeutics company. Pomerantz held senior roles at multiple pharmaceutical companies, including as the Global Head of Infectious Disease at Johnson & Johnson and Head of Licensing and Acquisitions at Merck. He holds a BA in Biochemistry and an MD, both from The Johns Hopkins University.
'Morphoceuticals is building a platform that has the potential to transform human health,' said Pomerantz. 'I am proud to become the Chairman of its Board of Directors and collaborate with a first-rate team toward development of a tool with such enormous power.'
'It is a great honor to bring Roger into our company as we near completion of the toolkit necessary to build the first ever atlas of the bioelectrome,' said Jim Jenson, PhD, CEO of Morphoceuticals. 'With his expert guidance, and the extraordinary foundation laid by Drs. Michael Levin and David Kaplan, we can harness the power of non-neural bioelectric circuits that guide re-growth in the body into a platform technology that can address some of the most intractable healthcare challenges.'
Morphoceuticals is building on the groundbreaking work of its co-founders, Michael Levin, Vannevar Bush Professor of Biology in the School of Arts and Sciences, and David Kaplan, Stern Family Endowed Professor of Engineering in the School of Engineering, both of Tufts University, who successfully demonstrated limb regeneration in an African clawed frog, becoming the first to achieve functional limb regeneration in an adult animal of a species that does not naturally regenerate complex limbs in adulthood.
The company has secured more than $15 million in seed financings, initially led by Juvenescence and Prime Movers Lab.
ABOUT MORPHOCEUTICALS Morphoceuticals is a TechBio company focused on understanding and manipulating the bioelectrome to induce regeneration and treat disease. The bioelectrome is the set of electrical communication networks within the body that bind multi-cellular collectives together for a common purpose, maintaining tissue and organ level integrity and health. We are building an atlas of the bioelectrome using our world-first suite of model systems and proprietary AI techniques. By understanding and manipulating these networks, we aim to rewrite them for the treatment of conditions that are inadequately addressed by existing therapeutic strategies. At Morphoceuticals, we are reprogramming the software of life. For more information visit www.morphoceuticals.com
Media Contact Michael FalconePearl Street Partnersmichael@pearlst.com617-990-6712
A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/08bfec7a-ddc5-4597-8ed6-75eaca516d69
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
18 minutes ago
- Yahoo
North America Leads in MRD Testing Market with Advanced Reimbursement Ecosystem
The Minimal Residue Disease (MRD) Testing Market is projected to reach USD 4.50 billion by 2030, with a CAGR of 10.1% from 2025. Key drivers include the rising use of MRD tests in cancer prognosis and personalized medicine. In 2024, flow cytometry and hematological malignancies held major market shares. North America leads due to advanced diagnostics and healthcare infrastructure. This report offers comprehensive insights and strategic recommendations. Minimal Residual Disease Testing Market Dublin, July 25, 2025 (GLOBE NEWSWIRE) -- The "Minimal Residual Disease Testing Market Size, Share & Trends Analysis Report By Technology (NGS, PCR), By Cancer Type (Hematological Malignancy, Solid Tumors), By End-use (Hospitals, Diagnostic Laboratories), By Region, And Segment Forecasts, 2025 - 2030" report has been added to global minimal residual disease testing market size is estimated to reach USD 4.50 billion by 2030, registering a CAGR of 10.1% from 2025 to 2030. The adoption of MRD testing as a novel diagnostic and prognostic assay facilitates robust moderation of treatment regimes to treat all kinds of hematological malignancies. Measurement of therapeutic outcomes is critical for the successful adoption of a given cancer therapeutic regime. MRD generates important molecular information to better understand the cancer conditions and ultimately work towards leveraging treatment outcomes. Therefore, MRD testing is increasingly used as an end-point analysis step in numerous clinical trial studies for oncology-based research and also effectively records the variations in outcomes due to individual genetic characteristics. For instance, in November 2020, Adaptive Biotechnologies Corporation, entered into a collaboration with GlaxoSmithKline plc., to use its clonoSEQ assay for the assessment of residual cancer cells after treatment with GSK's hematology removal of tumors with other associative therapies does not essentially mean, that the cancerous cells are removed completely. Traces of cancer can remain in the body parts and bloodstream. The diagnosis of such residual cells is crucial for deciding upon the need for further rounds of chemotherapy and radiation. Researchers are devising non-invasive tests to effectively detect MRD. For instance, in February 2022, a blood test from C2i Genomics quantified the residual cancer cells after surgical oncology procedures. The C2inform test also achieved the CE mark clearance and is offered as a 'software-as-a-medical-device' MRD test in therapeutics are effectively moderated to avoid a residue of tumorous cells using the relevant clinical evidence and are also personalized based on specific progression profiles in an individual. Numerous research studies are driving the need for consideration of individual genetic characteristics for effective Residue Disease Testing Market Report Highlights By technology, the flow cytometry segment held a dominant share in the minimal residual disease testing market in 2024, owing to the high sensitivity and wide applicability of MRD testing. By cancer type, the hematological malignancy cancer dominated the market with a revenue share of 68.58% in 2024, owing to the increasing prevalence of hematological malignancy. By end-use, the hospitals and specialty clinics segment is the highest revenue-generating segment in 2024, owing to the availability of advanced diagnostic devices and skilled professionals in hospitals and specialty clinics. North America dominated the minimal residual disease testing market in 2024, which is attributed to the growing prevalence of hematological malignancies in the region aided by a well-developed reimbursement landscape. Key Attributes: Report Attribute Details No. of Pages 320 Forecast Period 2024 - 2030 Estimated Market Value (USD) in 2024 $2.5 Billion Forecasted Market Value (USD) by 2030 $4.5 Billion Compound Annual Growth Rate 10.1% Regions Covered Global Companies Featured Exact Sciences Corporation GRAIL, LLC Veracyte, Inc. Natera, Inc. Guardant Health F. Hoffmann-La Roche Ltd FOUNDATION MEDICINE, INC. QIAGEN mdxhealth Bio-Techne For more information about this report visit About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends. Attachment Minimal Residual Disease Testing Market CONTACT: CONTACT: Laura Wood,Senior Press Manager press@ For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900Sign in to access your portfolio
Yahoo
an hour ago
- Yahoo
U.S. High-Performance Trucks Market Report 2025: Analysis Through 2020-2030 by Vehicle Type, Fuel Type, Power Output and Region
Electrification is a key trend, with strong consumer interest in electric and hybrid trucks despite challenges from emissions regulations U.S. High-Performance Trucks Market Dublin, July 25, 2025 (GLOBE NEWSWIRE) -- The "United States High-Performance Trucks Market, By Region, Competition, Forecast & Opportunities, 2020-2030F" has been added to offering. The United States High-Performance Trucks Market was valued at USD 1.20 Billion in 2024, and is expected to reach USD 1.48 Billion by 2030, rising at a CAGR of 3.61%. The market is steadily expanding due to increasing consumer demand for robust trucks that offer superior towing power, off-road capabilities, and advanced technology features. These trucks are valued for their strength, reliability, and multifunctional utility, making them suitable for both professional and recreational use. Manufacturers are enhancing vehicle appeal by incorporating turbocharged engines, upgraded suspensions, and modern infotainment systems. The segment is gaining popularity among a diverse customer base seeking a blend of performance, utility, and premium features. Key Market Driver Rising Consumer Preference for Versatile Utility Vehicles: A key factor driving the growth of the U.S. high-performance trucks market is the growing consumer inclination toward versatile vehicles capable of fulfilling multiple roles. High-performance trucks have evolved from being solely work-related machines to serving as lifestyle vehicles. Consumers now seek models that can manage rigorous job-site duties while also supporting leisure activities such as boating, camping, or off-road adventures. The appeal lies in their powerful engines, ample towing capacity, and cargo space. These features resonate with a wide audience, from rural workers to suburban hobbyists. In response, automakers are increasingly equipping their truck lineups with luxury-grade interiors, safety innovations, and convenience features - merging rugged performance with upscale comfort. Key Market Challenge Stringent Emissions Regulations and Fuel Efficiency Standards: One of the major challenges confronting the high-performance trucks market in the United States is the tightening of emissions and fuel economy regulations. These trucks, designed for high output and off-road prowess, often rely on large engines that emit more pollutants and consume more fuel. Regulatory bodies, including the federal government and specific states like California, are enforcing stricter CAFE standards and emissions thresholds, compelling manufacturers to reduce environmental impact. Achieving compliance while preserving power and performance requires substantial investment in hybrid, electric, or alternative powertrain technologies. However, these solutions can be expensive to implement and may face resistance from traditional truck buyers accustomed to internal combustion performance, posing a hurdle to broader market acceptance. Key Market Trend Electrification of High-Performance Trucks: Electrification is emerging as a transformative trend in the U.S. high-performance trucks market. With mounting environmental concerns and stricter emission mandates, automakers are introducing electric and hybrid high-performance trucks. Vehicles like the Ford F-150 Lightning, Rivian R1T, and Tesla Cybertruck are redefining expectations by delivering exceptional torque, off-road capabilities, and quiet operation - alongside environmental benefits. These electric trucks are engineered to match or exceed the towing and payload capabilities of traditional combustion models while offering lower maintenance and operational costs. The Ford F-150 Lightning's impressive sales performance in 2024, reaching 33,510 units, a 39% increase from the previous year, demonstrates the rising consumer interest and momentum in this segment. Key Market Players Profiled: Scania AB MAN AB AB Volvo Tesla, Inc. Daimler Truck AG PACCAR Inc General Motors LLC Toyota Motor Corporation Ford Motor Company Nissan North America, Inc. Report Scope In this report, the United States High-Performance Trucks Market has been segmented into the following categories: United States High-Performance Trucks Market, By Vehicle Type: Medium & Heavy Duty Truck Pickup Truck United States High-Performance Trucks Market, By Fuel Type: Diesel CNG Others United States High-Performance Trucks Market, By Power Output: 250-400HP 401-550 HP >550HP United States High-Performance Trucks Market, By Region: South West Northeast Midwest Key Attributes Report Attribute Details No. of Pages 81 Forecast Period 2024-2030 Estimated Market Value (USD) in 2024 $1.2 Billion Forecasted Market Value (USD) by 2030 $1.48 Billion Compound Annual Growth Rate 3.6% Regions Covered United States For more information about this report visit About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends. Attachment U.S. High-Performance Trucks Market CONTACT: CONTACT: Laura Wood,Senior Press Manager press@ For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900Sign in to access your portfolio
Yahoo
an hour ago
- Yahoo
Middle East & North Africa Commercial Vehicles Market Report 2025: Challenges and Strategies for Commercial Vehicle Operators in MENA to 2030
Urban growth and large-scale infrastructure projects bolster fleet requirements, while e-commerce growth fuels last-mile delivery needs Middle Eastern & North African Commercial Vehicle Market Dublin, July 25, 2025 (GLOBE NEWSWIRE) -- The "Middle East & North Africa Commercial Vehicle Market, By Country, Competition, Forecast and Opportunities, 2020-2030F" has been added to offering. The Middle East & North Africa Commercial Vehicle Market was valued at USD 29.34 Billion in 2024, and is expected to reach USD 48.32 Billion by 2030, rising at a CAGR of 8.67%. The market is witnessing substantial expansion due to increasing demand across logistics, construction, and agriculture sectors. Rising urbanization and the execution of large-scale infrastructure projects across the region are generating significant opportunities for commercial vehicle deployment. As urban centers grow and supply chains expand, reliable transportation becomes essential, thereby boosting demand for commercial fleets. Additionally, the surge in e-commerce and the need for efficient last-mile delivery are contributing to the growing reliance on commercial vehicles in both rural and urban zones. Market Driver: Infrastructure Development The ongoing investment in infrastructure development across the MENA region is a key factor driving the commercial vehicle market. Governments and private developers are allocating substantial budgets to build roads, transportation hubs, and logistics corridors, which increase the requirement for trucks, vans, and buses. These vehicles play a critical role in transporting materials and people across rapidly evolving urban and industrial zones. Enhanced infrastructure improves connectivity and reduces transportation bottlenecks, encouraging businesses to expand their fleets. As trade and industrial activities scale up, demand for commercial vehicles continues to rise in line with the need for efficient, scalable, and sector-specific mobility solutions. Key Market Challenge: Fluctuating Fuel Prices The volatility of fuel prices poses a considerable challenge for commercial vehicle fleet operators across the MENA region. Fuel expenses account for a large portion of operating costs, and price fluctuations can negatively impact budgeting, profitability, and pricing strategies. Sudden spikes in fuel prices can lead to increased costs for logistics and transport companies, which may struggle to pass on these increases to customers. For operators managing large fleets, such unpredictability complicates financial planning and discourages long-term investment in vehicle acquisition or upgrades. While alternative fuel solutions are gaining interest, their adoption remains limited due to the high initial investment and infrastructure requirements. Key Market Trend: Electrification of Commercial Fleets The trend toward fleet electrification is gaining momentum in the MENA commercial vehicle market as stakeholders focus on sustainability and emissions reduction. Electric commercial vehicles are becoming increasingly attractive due to their lower operating costs and environmental benefits. Governments are introducing incentives and policies to promote clean mobility, while advancements in battery technology have improved vehicle range and cost-efficiency. The growing availability of charging infrastructure is further supporting this transition, especially in urban areas where EVs are well-suited for short to mid-range operations. Fleet owners are gradually adopting electric models to meet regulatory requirements, reduce dependency on fossil fuels, and align with ESG goals. Key Market Players Profiled: TATA Motors Ltd. MAN Truck & Bus Middle East FZE Ashok Leyland (U.A.E) L.L.C Mercedes-Benz Group AG Scania AB Toyota Motor Corporation Ab Volvo Isuzu Motors International FZE Zhengzhou Yutong Bus Co., Ltd. General Motors Corporation Report Scope In this report, the Middle East & North Africa Commercial Vehicle Market has been segmented into the following categories: Middle East & North Africa Commercial Vehicle Market, By Vehicle Type: Light Commercial Vehicle (LCV) Medium Commercial Vehicle (MCV) Heavy Commercial Vehicle (HCV) Middle East & North Africa Commercial Vehicle Market, By Propulsion Type: ICE Electric Middle East & North Africa Commercial Vehicle Market, By Application: Construction Logistics Mining Oil & Gas Others Middle East & North Africa Commercial Vehicle Market, By Country: Turkey Saudi Arabia Egypt UAE Israel Morocco Kuwait Key Attributes Report Attribute Details No. of Pages 135 Forecast Period 2024-2030 Estimated Market Value (USD) in 2024 $29.34 Billion Forecasted Market Value (USD) by 2030 $48.32 Billion Compound Annual Growth Rate 8.6% Regions Covered Africa, Middle East For more information about this report visit About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends. Attachment Middle Eastern & North African Commercial Vehicle Market CONTACT: CONTACT: Laura Wood,Senior Press Manager press@ For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900
